No Data
No Data
SeaStar Medical to Present at Noble Capital Markets' NobleCon20 on December 4, 2024
SeaStar Medical Advocates for Stockholder Support of Proxy Proposals Ahead of November 26 Special Meeting
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical's Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares
Maxim Group Maintains SeaStar Medical(ICU.US) With Buy Rating
Maxim Group Reaffirms Their Buy Rating on SeaStar Medical Holding (ICU)
SeaStar Medical Shares Are Trading Higher After the Company Announced the Shipment of Its 100th QUELIMMUNE Commercial Device to Its Third Hospital Customer.
No Data
No Data